Αποτελέσματα Αναζήτησης
A chronic disorder, possibly autoimmune, marked by excessive production of collagen which results in hardening and thickening of body tissues. The two types of systemic scleroderma, limited cutaneous and diffuse cutaneous are classified with focus on the extent of affected skin.
- M34.89
M34.89 is a billable/specific ICD-10-CM code that can be...
- M34.89
3 Νοε 2023 · Initial symptoms are non-specific and include fatigue, vague musculoskeletal complaints, diffuse swelling of hands, and Raynaud's phenomenon. Aetiology and pathogenesis are unknown. Disease course is variable, but the condition rarely subsides spontaneously.
15 Ιουν 2024 · Treatment. There is no treatment that can cure or stop the overproduction of collagen that happens in scleroderma. But a variety of treatments can help control symptoms and prevent complications.
29 Σεπ 2023 · How is scleroderma diagnosed? A healthcare provider will diagnose scleroderma with a physical exam and some tests. You might need to visit a rheumatologist, a healthcare provider who specializes in treating autoimmune disorders. They’ll examine your body and ask you about your symptoms.
In late 2013, the American College of Rheumatology (ACR) and the European League Against Rheumatism (EULAR) approved a new set of diagnostic criteria for systemic sclerosis (SSc), replacing the older 1980 diagnostic criteria.
5 Απρ 2024 · Continuing Education Activity. Systemic sclerosis or scleroderma is a rare connective tissue disorder with an unknown and complex pathogenesis. Scleroderma can be divided into 2 primary forms—localized scleroderma (including morphea, linear scleroderma, and scleroderma en coup de sabre) and systemic sclerosis.
15 Ιουν 2024 · Symptoms. Scleroderma symptoms vary from person to person, depending on which parts of the body are affected. Skin-related symptoms. Nearly everyone who has scleroderma experiences hardening and tightening of the skin. The first parts of the body to be affected are usually the fingers, hands, feet and face.
